Universal first-trimester cytomegalovirus screening and valaciclovir prophylaxis in pregnant persons: a cost-effectiveness analysis
Stephanie A. Fisher, Emily S. Miller, Lynn M. Yee, William A. Grobman, Ashish Premkumar
Topics & Concepts
ValaciclovirMedicineCytomegalovirusPregnancySerologyObstetricsCost effectivenessHuman cytomegalovirusPediatricsHerpesviridaeImmunologyViral diseaseHuman immunodeficiency virus (HIV)VirusAntibodyBiologyRisk analysis (engineering)GeneticsCytomegalovirus and herpesvirus researchHerpesvirus Infections and TreatmentsParvovirus B19 Infection Studies